Primary endpoints with efficacy under the bayesian probabilities, the DSMB will recommend to stop the trial. The sponsor being Icahn Hospital with Mesoblast most likely will concur.
Also, if above, secondary endpoints most likely will be positive too.
I would be shocked if they decide to continue.
- Forums
- ASX - By Stock
- MSB
- Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-155
-
- There are more pages in this discussion • 291 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 42268 | 94.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 48002 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 42268 | 0.940 |
10 | 206249 | 0.935 |
2 | 60714 | 0.930 |
7 | 112244 | 0.925 |
3 | 471786 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 48002 | 3 |
0.955 | 20000 | 1 |
0.960 | 87714 | 5 |
0.965 | 75937 | 4 |
0.970 | 268286 | 5 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
MSB (ASX) Chart |